BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8137286)

  • 21. Orthotopic model of canine osteosarcoma in athymic rats for evaluation of stereotactic radiotherapy.
    Schwartz AL; Custis JT; Harmon JF; Powers BE; Chubb LS; LaRue SM; Ehrhart NP; Ryan SD
    Am J Vet Res; 2013 Mar; 74(3):452-8. PubMed ID: 23438123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Helix pomatia agglutinin binding in human tumour cell lines: correlation with pulmonary metastases in nude mice.
    Kjønniksen I; Rye PD; Fodstad O
    Br J Cancer; 1994 Jun; 69(6):1021-4. PubMed ID: 8198963
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Scintigraphic appearance of uncommon soft-tissue osteogenic sarcoma metastases.
    Arrington ER; Eisenberg B; Orrison WW; Williamson MR
    J Nucl Med; 1990 May; 31(5):679-81. PubMed ID: 2341904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Atypical scintigraphic appearance of an osteosarcoma. An explanation using x-ray and histologic findings].
    Dörr U; Iglesias P; Bihl H
    Nuklearmedizin; 1992 Jun; 31(3):106-9. PubMed ID: 1641356
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of new-bone formation in the host bed by human bone-tumor transplants in athymic nude mice.
    Urist MR; Grant TT; Lindholm TS; Mirra JM; Hirano H; Finerman GA
    J Bone Joint Surg Am; 1979 Dec; 61(8):1207-16. PubMed ID: 229105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of an intramuscular xenograft model of canine osteosarcoma in mice for evaluation of the effects of radiation therapy.
    Coomer AR; Farese JP; Milner R; Taylor D; Salute ME; Rajon DA; Bova FJ; Siemann DW
    Am J Vet Res; 2009 Jan; 70(1):127-33. PubMed ID: 19119958
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thallium-201 scintigraphy in bone sarcoma: comparison with gallium-67 and technetium-MDP in the evaluation of chemotherapeutic response.
    Ramanna L; Waxman A; Binney G; Waxman S; Mirra J; Rosen G
    J Nucl Med; 1990 May; 31(5):567-72. PubMed ID: 2341892
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of a nitrogen-containing bisphosphonate, minodronate, in conjunction with a p38 mitogen activated protein kinase inhibitor or doxorubicin against malignant bone tumor cells.
    Kubo T; Shimose S; Matsuo T; Sakai A; Ochi M
    Cancer Chemother Pharmacol; 2008 Jun; 62(1):111-6. PubMed ID: 17874104
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radionuclide bone scanning of osteosarcoma: falsely extended uptake patterns.
    Chew FS; Hudson TM
    AJR Am J Roentgenol; 1982 Jul; 139(1):49-54. PubMed ID: 6283871
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of treatment with growth hormone and somatostatin on efficacy of diammine [1,1-cyclobutane dicarboxylato (2-)-0,0']-(SP-4-2) in athymic rats with osteosarcoma.
    Conzemius MG; Graham JC; Haynes JS; Graham CA
    Am J Vet Res; 2000 Jun; 61(6):646-50. PubMed ID: 10850839
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Localization of 99mTc methylene diphosphonate within synovial fluid in osteosarcoma.
    Sandler MS; Heyman S; Watts H
    AJR Am J Roentgenol; 1984 Aug; 143(2):349-50. PubMed ID: 6234787
    [No Abstract]   [Full Text] [Related]  

  • 32. [An experimental model of osteosarcomas in rats ].
    Jasmin C; Allouche M; Jude JG; Klein B; Thiéry JP; Perdereau B; Gongora R; Gongora G; Mazabraud A
    Sem Hop; 1982 Jul; 58(28-29):1684-9. PubMed ID: 6289449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel spontaneous metastasis model of human osteosarcoma developed using orthotopic transplantation of intact tumor tissue into tibia of nude mice.
    Crnalic S; Häkansson I; Boquist L; Löfvenberg R; Brostrom LA
    Clin Exp Metastasis; 1997 Mar; 15(2):164-72. PubMed ID: 9062393
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibitory effects of a new bisphosphonate, minodronate, on proliferation and invasion of a variety of malignant bone tumor cells.
    Kubo T; Shimose S; Matsuo T; Tanaka K; Yasunaga Y; Sakai A; Ochi M
    J Orthop Res; 2006 Jun; 24(6):1138-44. PubMed ID: 16705696
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-dose ifosfamide as second- or third-line chemotherapy in refractory bone and soft tissue sarcoma patients.
    Lee SH; Chang MH; Baek KK; Han B; Lim T; Lee J; Park JO
    Oncology; 2011; 80(3-4):257-61. PubMed ID: 21734417
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Significant antitumor effect from bone-seeking, alpha-particle-emitting (223)Ra demonstrated in an experimental skeletal metastases model.
    Henriksen G; Breistøl K; Bruland ØS; Fodstad Ø; Larsen RH
    Cancer Res; 2002 Jun; 62(11):3120-5. PubMed ID: 12036923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Virus-induced osteosarcoma in rats.
    Czitrom AA; Pritzker KP; Langer F; Gross AE; Luk SC
    J Bone Joint Surg Am; 1976 Apr; 58(3):303-8. PubMed ID: 1063127
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Multicentric osteosarcoma: report of a case with synchronous lesions].
    Maluf Júnior PT; Britto JL; Cristofani L; Cutait R; Odone Filho V
    Rev Hosp Clin Fac Med Sao Paulo; 1993; 48(5):231-4. PubMed ID: 8165410
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinico-morphologic characterization of lung metastases from osteogenic sarcoma during chemotherapy].
    Fedenko AN; Siniukov PA
    Arkh Patol; 1989; 51(3):22-8. PubMed ID: 2742512
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-dose ifosfamide with hematopoietic growth factor support in advanced bone and soft tissue sarcomas.
    Yalcin B; Pamir A; Buyukcelik A; Utkan G; Akbulut H; Demirkazik A; Icli F
    Exp Oncol; 2004 Dec; 26(4):320-5. PubMed ID: 15627067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.